Pairidex Inc.

Biotechnology company · St. Louis, Missouri, United States

Pairidex Inc. is a biotechnology company headquartered in St. Louis, Missouri, United States. Its earliest recorded incorporation is in 2023. It has reported private securities offerings to the US SEC, most recently $1.1 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Pairidex at a glance

Typebiotechnology company

HeadquartersSt. Louis, Missouri, United States

Earliest incorporation on record2023

SEC CIK2056818

What does Pairidex do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $1.1 million sold (2025).

Frequently asked questions about Pairidex

Where is Pairidex headquartered?

Pairidex Inc. is headquartered in St. Louis, Missouri, United States.

What does Pairidex do?

Pairidex Inc. is a biotechnology company.

When was Pairidex founded?

The earliest incorporation on record for Pairidex Inc. is in 2023, according to public company registers.

Similar companies

MediBeacon Inc.St. Louis, Missouri, United States
C2N Diagnostics, LLCSt. Louis, Missouri, United States
Pulse Therapeutics, Inc.St. Louis, Missouri, United States
Panome Bio Inc.St. Louis, Missouri, United States
Cardialen, Inc.St. Louis, Missouri, United States
Gateway Biotechnology, Inc.St. Louis, Missouri, United States
Confluence Life Sciences, Inc.St. Louis, Missouri, United States
BacterioScan, Inc.St. Louis, Missouri, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences